Elevated LAMTOR4 Expression Is Associated with Lethal Prostate Cancer and Its Knockdown Decreases Cell Proliferation, Invasion, and Migration In Vitro
International Journal of Molecular Sciences · 2024
DOI: 10.3390/ijms25158100 ↗Kurz gefasst
Fachartikel in der Zeitschrift International Journal of Molecular Sciences, 2024. Verfasst von Yaser Gamallat und 6 weiteren Autor:innen. Beteiligte Einrichtung: Department of Pathology and Laboratory Medicine, Cumming School of Medicine, University of Calgary, Calgary, AB T2N 4N1, Canada. Hauptthemen laut MEDLINE: Adaptor Proteins, Signal Transducing, Cell Movement, Cell Proliferation, Gene Expression Regulation, Neoplastic. Die Arbeit wurde bisher 3-mal zitiert (Crossref) und nennt 25 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Prostate Cancer Canada and The Canadian Cancer Society and proudly funded by the Canadian Cancer Society,, Prostate Cancer Foundation Young Investigator Award, Canadian Cancer Society.
Abstract (Originalsprache)
Late endosomal/lysosomal adaptor, MAPK and mTOR, or LAMTOR, is a scaffold protein complex that senses nutrients and integrates growth factor signaling. The role of LAMTOR4 in tumorigenesis is still unknown. However, there is a considerable possibility that LAMTOR4 is directly involved in tumor cell proliferation and metastasis. In the current study, we investigated the protein expression of LAMTOR4 in a cohort of 314 men who were undergoing transurethral resection of prostate (TURP) consisting of incidental, advanced and castration-resistant cases. We also correlated the data with ERG and PTEN genomic status and clinicopathological features including Gleason score and patients’ outcome. Additionally, we performed in vitro experiments utilizing knockdown of LAMTOR4 in prostate cell lines, and we performed mRNA expression assessment using TCGA prostate adenocarcinoma (TCGA-PRAD) to explore the potential differentially expressed genes and pathways associated with LAMTOR4 overexpression in PCa patients. Our data indicate that high LAMTOR4 protein expression was significantly associated with poor overall survival (OS) (HR: 1.44, CI: 1.01–2.05, p = 0.047) and unfavorable cause-specific survival (CSS) (HR: 1.71, CI: 1.06–2.77, p = 0.028). Additionally, when high LAMTOR4 expression was combined with PTEN-negative cases (score 0), we found significantly poorer OS (HR: 2.22, CI: 1.37–3.59, p = 0.001) and CSS (HR: 3.46, CI: 1.86–6.46, p < 0.0001). Furthermore, ERG-positive cases with high LAMTOR4 exhibited lower OS (HR: 1.98, CI: 1.18–3.31, p = 0.01) and CSS (HR: 2.54, CI: 1.32–4.87, p = 0.005). In vitro assessment showed that knockdown of LAMTOR4 decreases PCa cell proliferation, migration, and invasion. Our data further showed that knockdown of LAMTOR4 in the LNCaP cell line significantly dysregulated the β catenin/mTOR pathway and tumorigenesis associated pathways. Inhibiting components of the mTOR pathway, including LAMTOR4, might offer a strategy to inhibit tumor progression and metastasis in prostate cancer.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Pathology and Laboratory Medicine, Cumming School of Medicine, University of Calgary, Calgary, AB T2N 4N1, Canada.
- Departments of Oncology, Biochemistry and Molecular Biology, Cumming School of Medicine, University of Calgary, Calgary, AB T2N 4N1, Canada.
- Arnie Charbonneau Cancer Institute, Cumming School of Medicine, University of Calgary, Calgary, AB T2N 4N1, Canada.
- Departments of Mathematical and Statistical Sciences and Medical Oncology, Faculty of Medicine and Dentistry, University of Alberta, Edmonton, AB T6G 2R7, Canada.
- Tom Baker Cancer Center, Alberta Health Services, Calgary, AB T2N 4N1, Canada.
- Prostate Cancer Centre, Rockyview General Hospital, Calgary, AB T2V 1P9, Canada.
ORCID-Profile: Yaser Gamallat, Huseen Alwazan, Vincent Dang, Sima Seyedi, Sunita Ghosh, Tarek A Bismar
Förderung
- Prostate Cancer Canada and The Canadian Cancer Society and proudly funded by the Canadian Cancer Society,
- Prostate Cancer Foundation Young Investigator Award
- Canadian Cancer Society
Zitieren
APA
Gamallat, Y., Alwazan, H., Turko, R., Dang, V., Seyedi, S., Ghosh, S., & Bismar, T. A. (2024). Elevated LAMTOR4 Expression Is Associated with Lethal Prostate Cancer and Its Knockdown Decreases Cell Proliferation, Invasion, and Migration In Vitro. International Journal of Molecular Sciences. https://doi.org/10.3390/ijms25158100
Vancouver
Gamallat Y, Alwazan H, Turko R, Dang V, Seyedi S, Ghosh S, et al. Elevated LAMTOR4 Expression Is Associated with Lethal Prostate Cancer and Its Knockdown Decreases Cell Proliferation, Invasion, and Migration In Vitro. International Journal of Molecular Sciences. 2024. doi:10.3390/ijms25158100
BibTeX
@article{Gamallat2024,
author = {Gamallat, Yaser and Alwazan, Huseen and Turko, Rasoul and Dang, Vincent and Seyedi, Sima and Ghosh, Sunita and Bismar, Tarek A},
title = {Elevated LAMTOR4 Expression Is Associated with Lethal Prostate Cancer and Its Knockdown Decreases Cell Proliferation, Invasion, and Migration In Vitro},
journal = {International Journal of Molecular Sciences},
year = {2024},
doi = {10.3390/ijms25158100}
}
EUVIMED